How to Cite
Abstract
A new type of human coronavirus called SARS-CoV-2 causing COVID-19 disease, which manifests itself as a respiratory tract infection, has been the cause of a worldwide alarm state. SARS-CoV-2 is an RNA virus belonging to the Coronaviridae family, as well as the previous acute respiratory syndrome caused by coronavirus (SARS-CoV) and the respiratory syndrome of the Middle East (MERS-CoV). The source of the virus is not known with certainty, but it is associated with wild animals such as bats and intermediary reservoirs such as pangolin, snakes, and mink. The main contagion occurs through respiratory droplets and contact routes with people who have respiratory symptoms. The people most susceptible to presenting the most serious manifestations of the disease are those with comorbidities such as diabetes, high blood pressure, cardiovascular diseases and chronic respiratory diseases. Therapeutic management focuses on supportive measures and some drugs have undergone clinical trials to observe efficacy against SARS-CoV-2.
Keywords
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet [Internet]. 2020;395(10223):497–506. Available from: https://doi.org/10.1016/S0140-6736(20)30183-5
Centro de coordinación de alertas y emergencias sanitarias [Internet]. Ministerio de Sanidad, Consumo y Bienestar Social, Gobierno de España Feb 28, 2020. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/situacionActual.htm
Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging Coronavirus 2019-nCoV Pneumonia. Radiology [Internet]. 2020Jun;:200274. Available from: https://doi.org/10.1148/radiol.2020200274
Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, et al. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses [Internet]. 2020;12(2):244. Available from: https://doi.org/10.3390/v12020244
World Health Organization [Internet]. Coronavirus disease 2019 (COVID-19) Situation Report-143. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200611-covid-19-sitrep-143.pdf?sfvrsn=2adbe568_4
Diseases TLI. Challenges of coronavirus disease 2019. The Lancet Infectious Diseases [Internet]. 2020;20(3):261. Available from: https://doi.org/10.1016/S1473-3099(20)30072-4
Salata C, Calistri A, Parolin C, Palù G. Coronaviruses: a paradigm of new emerging zoonotic diseases. Pathogens and Disease [Internet]. 2019Jan;77(9). Available from: https://doi.org/10.1093/femspd/ftaa006
Ramaiah A, Arumugaswami V. Insights into Cross-species Evolution of Novel Human Coronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development. 2020; Available from: https://doi.org/10.1101/2020.01.29.925867
Reina J, Reina N. El coronavirus causante del síndrome respiratorio de Oriente Medio. Medicina Clínica [Internet]. 2015;145(12):529–31. Available from: http://dx.doi.org/10.1016/j.medcli.2015.09.014
Centro de Coordinación de Alertas y Emergencias Sanitarias [Internet]. Enfermedad por coronavirus, COVID-19 Mar 26, 2020. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/20200326_ITCoronavirus.pdf
Dashraath P, Jeslyn WJL, Karen LMX, Min LL, Sarah L, Biswas A, et al. Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. American Journal of Obstetrics and Gynecology [Internet]. 2020; Available from: https://doi.org/10.1016/j.ajog.2020.03.021
Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. Bmj [Internet]. 2020;:m1198. Available from: https://doi.org/10.1136/bmj.m1198
Ministerio de Salud de Costa Rica [Internet]. Lineamientos nacionales para la vigilancia de la enfermedad COVID-19, San José; 2020 p. 4–24. Available from: https://www.ministeriodesalud.go.cr/sobre_ministerio/prensa/docs/lineamientos_nacionales_vigilancia_infeccion_coronavirus_21052020_v13.pdf
Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA) [Internet]. Información general y lineamientos nacionales sobre la enfermedad por coronavirus (COVID-19) Mar 5, 2020. Available from: https://www.inciensa.sa.cr/actualidad/noticias/Informacion_general_y_lineamientos_nacionales_sobre_la%20enfermedad_por_coronavirus(COVID-19).aspx
Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations [Internet]. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations Mar 29, 2020. Available from: https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations
Trilla A. Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19. Medicina Clínica [Internet]. 2020;154(5):175–7. Available from: https://doi.org/10.1016/j.medcli.2020.02.002
Azamfirei R. The 2019 Novel Coronavirus: A Crown Jewel of Pandemics? The Journal of Critical Care Medicine [Internet]. 2020;6(1):3–4. Available from: https://doi.org/10.2478/jccm-2020-0013
Ena J, Wenzel R. Un nuevo coronavirus emerge. Revista Clínica Española [Internet]. 2020;220(2):115–6. Available from: https://doi.org/10.1016/j.rce.2020.01.001
Center for Disease Control and Prevention [Internet]. Coronavirus Disease 2019 (COVID-19). Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. Journal of Hospital Infection [Internet]. 2020;104(3):246–51. Available from: https://doi.org/10.1016/j.jhin.2020.01.022
Chen P, Mao L, Nassis GP, Harmer P, Ainsworth BE, Li F. Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions. Journal of Sport and Health Science [Internet]. 2020;9(2):103–4. Available from: https://doi.org/10.1016/j.jshs.2020.02.001
Ministerio de Sanidad, Consumo y Bienestar Social, Gobierno de España [Internet]. Manejo clínico de pacientes con enfermedad por el nuevo coronavirus COVID-19, Madrid; 18 mayo 2020 Available from: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Protocolo_manejo_clinico_ah_COVID-19.pdf
Jean S-S, Lee P-I, Hsueh P-R. Treatment options for COVID-19: the reality and challenges. Journal of Microbiology, Immunology and Infection [Internet]. 2020; Available from: https://doi.org/10.1016/j.jmii.2020.03.034
B. Cao, Y. Wang, D. Wen, W. Liu, Jingli Wang, G. Fan, et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. The New England Journal of Medicine, [online] (19), pp.1787-1799. Available at: https://doi.org/10.1056/NEJMoa2001282
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet [Internet]. 2020; Available from: https://doi.org/10.1016/S0140-6736(20)31180-6
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19 — Preliminary Report. New England Journal of Medicine [Internet]. 2020; Available from: https://doi.org/10.1056/NEJMoa2007764
Mayo clinic [Internet]. Convalescent plasma therapy. Available from: https://www.mayoclinic.org/tests-procedures/convalescent-plasma-therapy/about/pac-20486440?p=1